Immunogenicity and Immune Silence in Human Cancer is a research paper published in Frontiers in Immunology (2020). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R35 CA220500
NCI NIH HHS
Grant: U54 CA232568
National Institutes of Health
Grant: 3U54CA232568-01S4
Discovery and Development of Optimal Immunotherapeutic Strategies for Childhood Cancers
National Institutes of Health
Grant: 1R35CA220500-01
Discovering mechanisms of neuroblastoma tumorigenesis to improve patient outcomes
National Institutes of Health
Grant: 3U54CA232568-01S2
Engaging and Enhancing Neuroblastoma Immune Targeting
National Cancer Institute
Stand Up To Cancer
FWCI
1.75
Citation Percentile
0.9%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Genomic and transcriptomic profiling of combined small-cell lung cancer through microdissection: unveiling the transformational pathway of mixed subtype
Additional file 1 of Genomic and transcriptomic profiling of combined small-cell lung cancer through microdissection: unveiling the transformational pathway of mixed subtype
Additional file 2 of Genomic and transcriptomic profiling of combined small-cell lung cancer through microdissection: unveiling the transformational pathway of mixed subtype
Additional file 2 of Genomic and transcriptomic profiling of combined small-cell lung cancer through microdissection: unveiling the transformational pathway of mixed subtype